Lombardi: Stock Market Commentary & Forecasts, Financial & Economic Analysis Since 1986

Earnings Picture Starts off Bright with Oracle

Friday, December 21st, 2012
By for Profit Confidential

Earnings Picture Starts off BrightYou know the stock market is stuck in a rut when it doesn’t react to news, either good or bad. That’s the market we have now: directionless trading with no real expectation of a trend. Part of the current stock market malaise has to do with political negotiations regarding the fiscal cliff and the uncertainty this creates. Any final agreement on the issue should help the stock market; this can’t happen soon enough.

The Dow Jones Transportation Index (or average) has been surprisingly strong over the last several weeks. The bounceback was likely due to a combination of factors, including a technical rebound among many components and lower diesel prices. This index has been a real laggard in the stock market, and it really has to break 5,400 to signal any lasting bullish sentiment.

Corporate earnings from Oracle Corporation (NASDAQ/ORCL) were good, and it’s a sign that enterprises are spending on information technology to improve productivity. There’s been a lot of uneven share price action among large-cap technology stocks. Enterprise-level technology companies are outperforming more consumer-oriented businesses, and this highlights the reticence consumers have to spend. There’s also a technology migration taking place, and it’s away from the personal computer (PC) and Microsoft Corporation’s (NASDAQ/MSFT) “Windows” operating system.

Oracle’s stock market chart is below:

ORCL Oracle Crop, Nasdaq stock market chart

Chart courtesy of www.StockCharts.com

  • Still worried about the economy? Become an elite charter member of George's DAILY PROFITS and you could...

    TRIPLE YOUR MONEY IN A MONTH!

    George gave us the $2.8-billion IT infrastructure provider, up 4,745.20%; the $1.8-billion advertising agency, up 1,295.44%; and the $762-million business software company, up 1,213.19%.

    Only charter members can follow George daily.

    Learn how here!

One of the strongest indices over the last 12 months has been the NASDAQ Biotechnology Index. Many biotechnology stocks have been the market’s best performers this year. Not too long ago, we looked at Alexion Pharmaceuticals, Inc. (NASDAQ/ALXN) in this column. . (See “It’s a Traders’ Market with Only a Few Stocks Doing Great.”) This stock experienced a well-deserved price correction after going up for two years straight. It is in a tentative recovery now, and the company’s earnings estimates keep going up. Alexion is a liquid biotechnology stock that’s good for traders. The company’s stock market chart is featured below:

ALXN Alexion Pharmaceuticals, Nasdaq stock market chart

Chart courtesy of www.StockCharts.com

I’m becoming a little more bullish on corporate earnings as the year comes to an end. If we get strong earnings growth from technology and financial stocks, then the stock market is going to materially advance. There is an economic recovery at hand, and the latest gross domestic product (GDP) numbers on the U.S. economy were surprisingly good. The key, I would say, is for this recovery not to get messed up by some outside shock. Regardless of the numbers, however, investor sentiment is taking a hit in the absence of a solid deal on the fiscal cliff.

As a group, the financials report their quarterly earnings very soon in the New Year, and as always, they will set the tone for the rest of the earnings season. Another quarter of revenue weakness is likely, with big multinationals operating in Europe and China. The best prospects for earnings growth should be from companies with large domestic operations. Earnings from railroad stocks will also be an important indicator.

VN:F [1.9.22_1171]
Rating: 10.0/10 (1 vote cast)
VN:F [1.9.22_1171]
Rating: 0 (from 0 votes)
Earnings Picture Starts off Bright with Oracle, 10.0 out of 10 based on 1 rating

This is an entirely free service. No credit card required.

We hate spam as much as you do.
Check out our privacy policy.

Mitchell Clark - Equity Markets Specialist, Financial AdvisorMitchell Clark, B. Comm. is a Senior Editor at Lombardi Financial specializing in large- and micro-cap stocks. He’s the editor of a variety of popular Lombardi Financial newsletters, such as Income for Life and Micro-Cap Reporter. Mitchell, who has been with Lombardi Financial for 17 years, won the Jack Madden Prize in economic history and is a long-time student of equity markets. Prior to joining Lombardi, Mitchell was as a stock broker for a large investment bank. Add Mitchell Clark to your Google+ circles